Marshwinds Advisory’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-41,015
Closed -$3.29M 140
2016
Q4
$3.29M Sell
41,015
-350
-0.8% -$27.8K 1.57% 22
2016
Q3
$3.3M Sell
41,365
-600
-1% -$48.4K 1.61% 20
2016
Q2
$3.27M Sell
41,965
-1,200
-3% -$85.6K 1.59% 21
2016
Q1
$2.37M Sell
43,165
-450
-1% -$24.5K 1.22% 30
2015
Q4
$2.69M Sell
43,615
-425
-1% -$26.8K 1.41% 26
2015
Q3
$2.78M Sell
44,040
-1,000
-2% -$71.4K 1.49% 22
2015
Q2
$3.29M Sell
45,040
-2,925
-6% -$211K 1.66% 20
2015
Q1
$3.14M Sell
47,965
-350
-0.7% -$23.3K 1.48% 20
2014
Q4
$3.14M Sell
48,315
-400
-0.8% -$25.8K 1.48% 20
2014
Q3
$2.93M Sell
48,715
-700
-1% -$45.7K 1.45% 21
2014
Q2
$3.42M Sell
49,415
-416
-0.8% -$27K 1.65% 17
2014
Q1
$3.26M Sell
49,831
-100
-0.2% -$6.51K 1.64% 16
2013
Q4
$3.09M Buy
49,931
+700
+1% +$40.5K 1.64% 16
2013
Q3
$2.64M Sell
49,231
-325
-0.7% -$16.7K 1.52% 19
2013
Q2
$2.26M Buy
+49,556
New +$2.15M 1.34% 25

Other funds holding STJ

Marshwinds Advisory's STJ Position: Q1 2017 in Review

Marshwinds Advisory sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 41,015 shares — an estimated $3.29M sold.

Marshwinds Advisory first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $3.42M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Marshwinds Advisory reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Marshwinds Advisory sold 41,015 St Jude Medical shares in Q1 2017, an estimated $3.29M.
  • Marshwinds Advisory first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Marshwinds Advisory's St Jude Medical position peaked at $3.42M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Marshwinds Advisory's 13F filing for Q1 2017, filed 12 Apr 2017.